Circadian Rhythm Modulation by Dietary Phosphorus in Chronic Kidney Disease
NCT01341678 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2014-02-11
Summary
The purpose of this study is to describe the circadian rhythm of serum and salivary phosphorus in patients with chronic kidney disease and determine its' modification in response to changes in dietary phosphate load.
Conditions
Interventions
- DRUG
-
Lanthanum Carbonate
Diet will be supplemented with 1000mg at each meal
- DIETARY_SUPPLEMENT
-
NeutraPhos
Diet will be supplemented with NeutraPhos
- OTHER
-
Diet Only
Diet containing 1500mg of phosphorus
Sponsors & Collaborators
-
Geoffrey Block
lead OTHER
Principal Investigators
-
Geoffrey A Block, MD · Denver Nephrologists, PC
Study Design
- Allocation
- NON_RANDOMIZED
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-04-30
- Primary Completion
- 2011-10-31
- Completion
- 2011-10-31
Countries
- United States
Study Locations
More Related Trials
-
Determining Oral Phosphate Tolerance Across the Spectrum of Glomerular Filtration Rate
NCT02672293 ·Status: COMPLETED ·Phase: NA
-
Study in Chronic Kidney Disease (CKD) Not on Dialysis
NCT01110629 ·Status: COMPLETED ·Phase: PHASE3
-
Fosrenol and Phosphorus Balance - Lanthanum Carbonate
NCT01581996 ·Status: COMPLETED ·Phase: NA
-
Long-term Study in Chronic Kidney Disease (Extension From Study 14817)
NCT01187628 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease
NCT00151918 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults
NCT00880750 ·Status: COMPLETED ·Phase: PHASE1
-
Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis
NCT00704678 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis
NCT00704483 ·Status: COMPLETED ·Phase: PHASE2
-
Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5
NCT00452478 ·Status: TERMINATED ·Phase: PHASE4
-
Study of Phosphate Levels in Patients With Chronic Kidney Disease
NCT00824460 ·Status: COMPLETED ·Phase: PHASE2
-
Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis Patients
NCT01427907 ·Status: COMPLETED ·Phase: PHASE4
-
An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney Disease
NCT01574326 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4
NCT01277497 ·Status: TERMINATED ·Phase: PHASE4
-
The Impact of Phosphate Metabolism on Healthy Aging
NCT03771105 ·Status: SUSPENDED ·Phase: EARLY_PHASE1
-
Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)
NCT00843349 ·Status: COMPLETED ·Phase: NA
-
Study of Dietary Additive Phosphorus on Proteinuria and Fibroblast Growth Factor-23
NCT02020785 ·Status: COMPLETED ·Phase: NA
-
Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKD
NCT01128179 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Reducing Phosphorus Absorption on Cardiac Biomarkers in Hemodialysis Patients
NCT01781156 ·Status: UNKNOWN
-
Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteers
NCT00875017 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder
NCT04440696 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)
NCT00567723 ·Status: COMPLETED
-
Clinical Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis
NCT04767581 ·Status: COMPLETED ·Phase: PHASE3
-
Head to Head Study Against Sevelamer Hydrochloride
NCT00441545 ·Status: COMPLETED ·Phase: PHASE3
-
Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on Hemodialysis
NCT01736150 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment
NCT01316055 ·Status: COMPLETED ·Phase: PHASE1